138091-52-8Relevant articles and documents
TRIAZA-SPIRODECANONES AS DDR1 INHIBITORS
-
Page/Page column 78, (2017/01/26)
The present invention relates to compounds of formula (I) or pharmaceutically acceptable salts thereof, wherein L and R1 to R5 are as described herein, as well as processes for their manufacture, pharmaceutical compositions comprising them, and their use as medicaments.
TRICYCLIC SPIROCYCLE DERIVATIVES AND METHODS OF USE
-
Page/Page column 30, (2011/07/29)
The present invention relates to novel Tricyclic Spirocycle Derivatives, pharmaceutical compositions comprising the Tricyclic Spirocycle Derivatives and the use of these compounds for treating or preventing allergy, an allergy-induced airway response, congestion, a cardiovascular disease, an inflammatory disease, a gastrointestinal disorder, a neurological disorder, a metabolic disorder, obesity or an obesity-related disorder, diabetes, a diabetic complication, impaired glucose tolerance or aired fasting glucose.
Synthesis and characterization of selective dopamine D2 receptor antagonists. 2. Azaindole, benzofuran, and benzothiophene analogs of L-741,626
Vangveravong, Suwanna,Taylor, Michelle,Xu, Jinbin,Cui, Jinquan,Calvin, Wesley,Babic, Sonja,Luedtke, Robert R.,MacH, Robert H.
experimental part, p. 5291 - 5300 (2010/09/09)
A series of indole, 7-azaindole, benzofuran, and benzothiophene compounds have been prepared and evaluated for affinity at D2-like dopamine receptors. These compounds share structural elements with the classical D 2-like dopamine rec
